Early TNF-alpha levels suppression by upstream evolocumab use in patients with acute myocardial infarction undergoing percutaneous coronary intervention

Back

ESC2025 Premium Access

Early TNF-alpha levels suppression by upstream evolocumab use in patients with acute myocardial infarction undergoing percutaneous coronary intervention

Session: Pharmacotherapy in acute coronary syndromes (3)

Topic: Pharmacotherapy

Speaker: Doctor A. Marengo (Novara, IT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Alessandra Marengo

University Hospital Maggiore della Carita, Novara (Italy)

0 follower

6 more presentations in this session

Comparative effectiveness of prasugrel and ticagrelor among patients undergoing contemporary PCI: insights from the BMC2 registry

Speaker: Doctor E. Dayoub (Ann Arbor, US)

Colchicine for the secondary prevention of cardiovascular diseases: a cumulative-dose meta-analysis of randomized controlled trials including 31,397 subjects worldwide

Speaker: Assistant Professor Y. Chan (Hong Kong, HK)

Effect of early initiation of evolocumab on lipid profiles changes in patients with ACS Undergoing PCI (C-STAR)

Speaker: Associate Professor Y. Kim (Yongin, KR)

Direct oral anticoagulants vs. vitamin K antagonists for left ventricular thrombus: a paradigm shift in antithrombotic strategy?

Speaker: Doctor F. Veneziano (Rome, IT)

A very short duration of dual-antiplatelet therapy following percutaneous coronary intervention: a meta-analysis of randomized clinical trials

Speaker: Doctor J. Sakaleros (Bloomington, US)

Access the full session

Pharmacotherapy in acute coronary syndromes (3)

Speakers: Doctor A. Marengo, Doctor E. Dayoub, Assistant Professor Y. Chan, Associate Professor Y. Kim, Doctor F. Veneziano...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources